Cite
HARVARD Citation
Di Cosimo, S. et al. (2018). The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer: Results from Neo-ALTTO. European journal of cancer. pp. 42-48. [Online].